Evidence map›Paper›PMID 41756203›Full record

ArticleOpen forum infectious diseases2026

Diabetes Mellitus is a Risk Factor for Developing CMV Retinitis in Solid Organ Transplant Recipients: A Case-control Study.

Dilpreet K Bharaj, Shanil Dhanji, Elena Gurung, Gale Ladua, Christopher F Lowe, Nancy Matic, Justin Gill, Allison Mah, Alissa J Wright, David Ta Kim and 2 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Dilpreet K BharajFaculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0009-0000-1308-2234
Shanil DhanjiDepartment of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Elena GurungDepartment of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0009-0000-9449-3835
Gale LaduaDepartment of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0009-0006-4778-3702
Christopher F LoweDivision of Medical Microbiology and Virology, St.Paul's Hospital, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0000-0001-9320-4499
Nancy MaticDivision of Medical Microbiology and Virology, St.Paul's Hospital, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0000-0002-4158-6955
Justin GillDepartment of Medicine, Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.
Allison MahDepartment of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada.
Alissa J WrightDepartment of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada.
David Ta KimDepartment of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0000-0002-2604-6205
Kaivon Pakzad-VaeziDepartment of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Sara BelgaDepartment of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0000-0003-1725-1407

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The incidence of cytomegalovirus retinitis (CMVR) in solid organ transplant (SOT) recipients may be increasing due to improved long-term survival post-transplant. However, the epidemiology of CMVR after SOT is not well described. We therefore aimed to determine the incidence of CMVR and identify risk factors for its development post-SOT. Method: Case-control study at a 1:4 ratio between January 1, 2012 and March 31, 2024. Cases were SOT recipients at 1 of 2 British Columbia transplant centres diagnosed with CMVR clinically or through ocular fluid viral PCR. Controls were matched on transplant organ, year, and center. Univariable and multivariable analyses were performed using conditional logistic regression models. Results: Out of 5877 SOT recipients followed during the study period, there were 16 CMVR cases with an incidence rate of 5.3 per 10 000 person-years. Fourteen eligible cases of CMVR were matched to 56 controls. Cases were older than controls (median age 60.9 vs 42.6 years) and more likely to have diabetes mellitus (DM) (9 [64.3%] vs 9 [16.4%]), chronic heart disease (4 [28.6%] vs 4 [7.3%]), and CMV DNAemia any time post-SOT (12 [85.7%] vs 19 [35.2%]). Most received kidney transplants (50.0%), and the median time to CMVR was 3.4 years. After adjusting for age at transplant, DM, chronic heart disease, CMV DNAemia, and significant lymphopenia, only DM was associated with an increased odds of CMVR (odds ratio 16.5 [95% confidence interval, 1.12-243.8]). Conclusions: CMVR is a rare and late complication post-SOT. DM was independently associated with increased odds of CMVR post-SOT.

Indexed as

cytomegalovirus (CMV)retinitisrisk factorssolid organ transplantation (SOT)

Identifiers

PMID41756203
PMCPMC12934348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.